HomeInsightsPE

Glenmark Life Sciences Ltd PE Ratio

Glenmark Life Sciences Ltd PE Ratio

stocks purchased

₹ 5.9 Cr

Volume transacted

stocks purchased

46.2 K

stocks traded

Last Updated time: 10 Sep 15:30 PM

Image

Glenmark Life Sciences Ltd

NSE: GLS

PE

33.1

Last updated: 10 Sep 15:30 PM

Key Highlights

  • The P/E Ratio of Glenmark Life Sciences Ltd is 33.1 as of 10 Sep 15:30 PM.
  • The P/E Ratio of Glenmark Life Sciences Ltd changed from 13.4 on March 2019 to 20.2 on March 2024 . This represents a CAGR of 14.66% over 3 years. .
  • The Latest Trading Price of Glenmark Life Sciences Ltd is ₹ 1285 as of 10 Sep 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 18.7. The PE Ratio of IT - Software industry is 29.8. The PE Ratio of Pharmaceuticals industry is 40.1. The PE Ratio of Retail industry is 168.5. The PE Ratio of Textiles industry is 35.3. In 2024.

Historical P/E Ratio of Glenmark Life Sciences Ltd

No data available

Company Fundamentals for Glenmark Life Sciences Ltd

No data available

Image

Glenmark Life Sciences Ltd

NSE: GLS

PRICE

1285.3

77.20 (6.39%)

stock direction

Last updated: 10 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Glenmark Life Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

SWOT Analysis Of Glenmark Life Sciences Ltd

Strength

2

S

Weakness

2

W

Opportunity

1

O

Threats

0

T

BlinkX Score for Glenmark Life Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Glenmark Life Sciences Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Glenmark Life Sciences Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Glenmark Life Sciences Ltd

No data available

* All values are in crore

Historical Revenue of Glenmark Life Sciences Ltd

No data available

* All values are in crore

Historical EBITDA of Glenmark Life Sciences Ltd

No data available

* All values are in crore

Historical Net Profit of Glenmark Life Sciences Ltd

No data available

* All values are in crore

Historical Dividend Payout of Glenmark Life Sciences Ltd

No data available

* All values are in %

About Glenmark Life Sciences Ltd

  • Glenmark Life Sciences Limited was incorporated as Zorg Laboratories Private Limited', on June 23, 2011 at Pune and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra at Pune.
  • Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited' dated 10 August 2018.
  • A shareholders' resolution was passed on 13 August 2018 to convert the Company from a Private Limited Company to a Public Limited Company and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC.
  • The Company is a wholly owned Subsidiary of Glenmark Pharmaceuticals Limited.
  • The Company acquired API Division of Glenmark Pharmaceuticals Limited (the parent company) on 01 January, 2019.

Glenmark Life Sciences Ltd News Hub

News

Glenmark Life Sciences AGM scheduled

Glenmark Life Sciences announced that the Annual General Meeting (AGM) of the company will...

Read more

06 Sep 202416:35

News

Glenmark Life Sciences Ltd leads gainers in 'A' group

Tamilnad Mercantile Bank Ltd, Marico Ltd, Rossari Biotech Ltd and Nestle India Ltd are amo...

Read more

05 Aug 202412:00

News

Glenmark Life drops after Q1 PAT slides 18% YoY to Rs 111 cr

Revenue from operations rose 1.75% YoY to Rs 588.62 crore in the first quarter of FY25. Pr...

Read more

26 Jul 202412:21

News

Glenmark Life Sciences to hold board meeting

Glenmark Life Sciences will hold a meeting of the Board of Directors of the Company on 25 ...

Read more

19 Jul 202410:41

News

Glenmark Life drops after Q4 PAT slides 33% YoY to Rs 98 cr; Generic API biz down 8% YoY

Revenue from operations fell 13.64% YoY to Rs 536.59 crore in Q4 FY24. Profit before tax d...

Read more

25 Apr 202415:41

News

Glenmark Life Sciences director resigns

Glenmark Life Sciences announced that Gita Nayyar (DIN: 07128438), has tendered her resign...

Read more

22 Apr 202411:10

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Glenmark Life Sciences Ltd

What is the current PE Ratio of Glenmark Life Sciences Ltd?

The Current PE Ratio of Glenmark Life Sciences Ltd is 33.13 as on 10 Sep 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.1 as on 10 Sep 2024.

What was the PE Ratio of Glenmark Life Sciences Ltd last year?

The PE Ratio of Glenmark Life Sciences Ltd was 10.28 last year, now the PE ratio is 33.13, showing a year-on-year growth of 222.3%.

What does the PE Ratio of Glenmark Life Sciences Ltd indicate about its stock?

The PE Ratio of Glenmark Life Sciences Ltd is 33.13. This ratio indicates that investors are willing to pay 33.13 times the earnings per share for each share of Glenmark Life Sciences Ltd.

What is the PE Ratio Growth of Glenmark Life Sciences Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Glenmark Life Sciences Ltd grew by 222.3% whereas, the EPS ratio grew by 13.9.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*